---
title: "Neostigmine - Myasthenia Gravis"
sidebar: mydoc_sidebar
permalink: db01400-mesh-d009157-1.html
toc: false 
---


Path ID: `DB01400_MESH_D009157_1`
{% include image.html url="images/db01400-mesh-d009157-1.png" file="db01400-mesh-d009157-1.png" alt="db01400-mesh-d009157-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D009388 | Neostigmine | Drug |
| UniProt:P22303 | Acetylcholinesterase | Protein |
| GO:0006581 | Acetylcholine catabolic process | BiologicalProcess |
| GO:0015464 | Acetylcholine receptor activity | MolecularActivity |
| MESH:D000109 | Acetylcholine | ChemicalSubstance |
| MESH:D009157 | Myasthenia gravis | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Neostigmine | DECREASES ACTIVITY OF | Acetylcholinesterase |
| Acetylcholinesterase | POSITIVELY REGULATES | Acetylcholine Catabolic Process |
| Acetylcholine Catabolic Process | DECREASES ABUNDANCE OF | Acetylcholine |
| Acetylcholine | INCREASES ACTIVITY OF | Acetylcholine Receptor Activity |
| Acetylcholine Receptor Activity | DISRUPTED BY | Myasthenia Gravis |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB01400#BE0000426](https://go.drugbank.com/drugs/DB01400#BE0000426)
  - [https://en.wikipedia.org/wiki/Myasthenia_gravis#Pathophysiology](https://en.wikipedia.org/wiki/Myasthenia_gravis#Pathophysiology)
